Stockreport

Qualigen Therapeutics Announces $4.5 Million Private Placement of Convertible Preferred Shares

Qualigen Therapeutics, Inc.  (QLGN) 
PDF Carlsbad, CA, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ:QLGN) ("Qualigen" or the "Company"), Qualigen Therapeutics, Inc., is a life science [Read more]